| Latest Kensey Nash News Headlines | | Date | Time | Source | | | 11/11/2009 | 12:03PM | PRNUS | Kensey Nash Receives FDA 510(k) Clearance for Porcine Dermis Biologic Product
Company's First ECM Approval
EXTON, Pa., Nov. 11 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY), a leading medical technology company that provides innovative resorbable biomaterial technology for a wide range of medical procedures, today announced that it has received 510(k) clearance for its first... More...>> |
| 10/09/2009 | 12:36PM | PRNUS | Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference
EXTON, Pa., Oct. 9 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) today announced that it will release its earnings results for its first quarter ended September 30, 2009 at 7:30 A.M. Eastern Time on Thursday, October 22, 2009.
Joe Kaufmann, President and CEO, will be hosting a teleconference discussing... More...>> |
| 09/29/2009 | 5:03PM | PRNUS | Kensey Nash to Present at the JMP Securities Fourth Annual Healthcare Focus Conference
EXTON, Pa., Sept. 29 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) is scheduled to present at the JMP Securities Fourth Annual Healthcare Focus Conference at The New York Palace in New York City on Tuesday, October 6, 2009.
Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's... More...>> |
| 09/16/2009 | 3:53PM | PRNUS | Kensey Nash to Present at the 2009 UBS Global Life Sciences Conference
EXTON, Pa., Sept. 16 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) is scheduled to present at the 2009 UBS Global Life Sciences conference at the Grand Hyatt New York in New York City on Monday, September 21, 2009.
Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation... More...>> |
| 08/20/2009 | 10:00AM | PRNUS | Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
WEST CHESTER and EXTON, Pa., Aug. 20 /PRNewswire-FirstCall/ -- Synthes, Inc. (SWX:SYST.VX), a leading global medical device company in the orthopaedic trauma, spine, and cranio-maxillofacial markets, and Kensey Nash Corporation (NASDAQ:KNSY), a leading developer and manufacturer of innovative regenerative medicine products... More...>> |
| 08/20/2009 | 7:30AM | PRNUS | Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2009 Financial Results
EXTON, Pa., Aug. 20 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY), a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today reported the results for its fourth quarter and fiscal year ended June 30, 2009.
Fourth Quarter... More...>> |
| 07/29/2009 | 4:47PM | PRNUS | Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2009 Earnings Release Date and Teleconference
EXTON, Pa., July 29 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) today announced that it will release its earnings results for its fourth quarter and fiscal year ended June 30, 2009 at 7:30 A.M. Eastern Time on Thursday, August 20, 2009.
Joe Kaufmann, President and CEO, will be hosting a teleconference... More...>> |
| 06/23/2009 | 7:30AM | PRNUS | ThromCat(R) XT(TM) Thrombectomy Catheter System Receives CE Mark
- KENSEY NASH EARNS $1.5M MILESTONE UNDER SPECTRANETICS AGREEMENT -
EXTON, Pa., June 23 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) today announced that the ThromCat(R) XT Thrombectomy Catheter System has been granted CE Marking approval which allows for the sale of the product throughout the European... More...>> |
| 06/10/2009 | 11:33AM | PRNUS | Kensey Nash to Present at the Jefferies 3rd Annual Healthcare Conference
EXTON, Pa., June 10 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) is scheduled to present at the Jefferies 3rd Annual Healthcare Conference on Thursday, June 18, 2009.
Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, beginning at approximately 9:00 a.m. (ET... More...>> |
| 05/26/2009 | 12:26PM | PRNUS | Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting
EXTON, Pa., May 26 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) announced that its cartilage repair device has been highlighted in two podium presentations at the 8th World Congress of the International Cartilage Repair Society (ICRS) Meeting held in Miami, FL on May 23-26, 2009. The pre-clinical... More...>> |
| 04/30/2009 | 10:46AM | PRNUS | Kensey Nash to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
EXTON, Pa., April 30 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) is scheduled to present at the Bank of America and Merrill Lynch 2009 Health Care Conference at The Palace Hotel in New York, on Wednesday, May 13, 2009.
Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's... More...>> |
| 04/22/2009 | 7:30AM | PRNUS | Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results
EXTON, Pa., April 22 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY), a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today reported the results for its third quarter and first nine months of fiscal year 2009.
Third Quarter... More...>> |
| 04/09/2009 | 5:14PM | PRNUS | Kensey Nash Corporation Announces Its Third Quarter 2009 Earnings Release Date and Teleconference
EXTON, Pa., April 9 /PRNewswire/ -- Kensey Nash Corporation (NASDAQ:KNSY) today announced that it will release its earnings results for its third quarter ended March 31, 2009 at 7:30 A.M. Eastern Time on Wednesday, April 22, 2009.
Joe Kaufmann, President and CEO, will be hosting a teleconference discussing the earnings... More...>> |
| 03/18/2009 | 7:42AM | PRNUS | Kensey Nash Announces 600,000 Share Stock Repurchase Program
EXTON, Pa., March 18 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) today announced that its board of directors has approved a stock repurchase. The new program allows the Company to repurchase up to a total of 600,000 of its issued and outstanding shares of Common Stock and has no scheduled expiration... More...>> |
| 03/13/2009 | 9:28AM | PRNUS | Kensey Nash to Participate in the Sidoti Thirteenth Annual New York Emerging Growth Institutional Investor Forum Conference
EXTON, Pa., March 13 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) is scheduled to present at the Sidoti Thirteenth Annual New York Emerging Growth Institutional Investor Forum at The Grand Hyatt in New York City on Tuesday, March 24, 2009.
Joseph W. Kaufmann, Kensey Nash's CEO, will deliver the Company's... More...>> |
| 03/13/2009 | 9:28AM | PRNUS | Kensey Nash Announces Director Resignation
EXTON, Pa., March 13 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY), a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today announced the resignation of Mr. Ceasar N. Anquillare from its Board of Directors. Mr. Anquillare... More...>> |
| 03/05/2009 | 10:08AM | PRNUS | Kensey Nash Announces Appointment of Chief Financial Officer
EXTON, Pa., March 5 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY), a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, is pleased to announce today the appointment of Michael Celano, C.P.A. as Chief Financial Officer effective... More...>> |
| 02/24/2009 | 9:16AM | PRNUS | Kensey Nash Announces IDE Submission for Cartilage Repair Device
EXTON, Pa., Feb. 24 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) announced today that it has submitted an Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to study the use of the Company's unique biomaterials technology for treating articular cartilage... More...>> |
| 02/13/2009 | 3:31PM | PRNUS | Kensey Nash to Present at the Canaccord Adams Musculoskeletal Conference
EXTON, Pa., Feb. 13 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) is scheduled to present at the Canaccord Adams Musculoskeletal Conference at the University of Nevada in Las Vegas on Tuesday, February 24, 2009.
Douglas G. Evans, Kensey Nash's Chief Operating Officer, will deliver the Company's presentation... More...>> |
| 02/04/2009 | 1:11PM | PRNUS | Kensey Nash Announces Director Resignation
EXTON, Pa., Feb. 4 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY), a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today announced the resignation of Mr. Jeffrey C. Smith, Partner and Portfolio Manager of Ramius LLC, from... More...>> |
|